JSE gains as investors focus on vaccine rollouts and US stimulus deal
03 December 2020 - 10:33
The JSE was firmer on Thursday, with its global peers mixed as investors pin their hope on Covid-19 vaccine rollouts, while investor focus also remains on the US stimulus deal.
Now that Britain has beaten the rest of the world in approving a German-US Covid vaccine candidate, the US looks to be next in line, with the US Food and Drug Administration (FDA) decision on the shot expected in mid-December. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.